Ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate
C52H58Cl2F2N10O6 — CID 159813523
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate
Ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate (PubChem CID 159813523) has the molecular formula C52H58Cl2F2N10O6 and a molecular weight of 1028.00 g/mol. Its IUPAC name is ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate.
Molecular Properties
| Compound Name | Ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate |
|---|---|
| PubChem CID | 159813523 |
| Molecular Formula | C52H58Cl2F2N10O6 |
| Molecular Weight | 1028.00 g/mol |
| Exact Mass | 1026.39 |
| IUPAC Name | ethyl 4-[[6-[(2-tert-butylpyrazol-3-yl)amino]-2-pyridinyl]methyl]-1-(3-chloro-2-fluorobenzoyl)piperidine-4-carboxylate;ethyl 1-(3-chloro-2-fluorobenzoyl)-4-[[6-(1H-pyrazol-5-ylamino)-2-pyridinyl]methyl]piperidine-4-carboxylate |
| SMILES | CCOC(=O)C1(Cc2cccc(Nc3ccn[nH]3)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1.CCOC(=O)C1(Cc2cccc(Nc3ccnn3C(C)(C)C)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1 |
| InChI | InChI=1S/C28H33ClFN5O3.C24H25ClFN5O3/c1-5-38-26(37)28(13-16-34(17-14-28)25(36)20-9-7-10-21(29)24(20)30)18-19-8-6-11-22(32-19)33-23-12-15-31-35(23)27(2,3)4;1-2-34-23(33)24(15-16-5-3-8-19(28-16)29-20-9-12-27-30-20)10-13-31(14-11-24)22(32)17-6-4-7-18(25)21(17)26/h6-12,15H,5,13-14,16-18H2,1-4H3,(H,32,33);3-9,12H,2,10-11,13-15H2,1H3,(H2,27,28,29,30) |
| InChIKey | NLIFXJJVKPBISJ-UHFFFAOYSA-N |
| XLogP | 9.97 |
| TPSA | 189.56 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1028.00 |
| LogP ≤ 5 | 9.97 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159813523 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.